Cargando…

Antithrombin III levels in critically ill surgical patients: do they correlate with VTE?

OBJECTIVE: Antithrombin III (ATIII) deficiency may result from hereditary or acquired reduction in ATIII levels and is associated with an increase in venous thromboembolism (VTE) in the general population. VTE is a potentially preventable complication in the critically ill surgical patients. The obj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhatti, Umar F, Dhillon, Navpreet K, Mason, Russell, Wang, Andrew, Hashim, Yassar M, Barmparas, Galinos, Ley, Eric J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277534/ https://www.ncbi.nlm.nih.gov/pubmed/37342817 http://dx.doi.org/10.1136/tsaco-2022-001009

Ejemplares similares

New cars on the highways: Trends in injuries and outcomes following ejection
por: Manguso, Nicholas, et al.
Publicado: (2019)

Characterizing the delays in adequate thromboprophylaxis after TBI
por: Dhillon, Navpreet K, et al.
Publicado: (2021)

The gap in operative exposure in trauma surgery: quantifying the benefits of an international rotation
por: Barmparas, Galinos, et al.
Publicado: (2019)

Overtransfusion of packed red blood cells during massive transfusion activation: a potential quality metric for trauma resuscitation
por: Barmparas, Galinos, et al.
Publicado: (2022)

Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis
por: Allingstrup, Mikkel, et al.
Publicado: (2016)

Fibrinogen and antithrombin III are associated with in-hospital mortality among critically ill patients with acute kidney injury
por: Zhang, Guangyuan, et al.
Publicado: (2022)

Risk of VTE in Nonrespiratory and Respiratory Presentations of COVID-19 in Critically Ill Patients
por: Roubinian, Nareg H., et al.
Publicado: (2023)

Does Beta-Blockade Reduce the Risk of Depression in Patients with Isolated Severe Extracranial Injuries?
por: Ahl, Rebecka, et al.
Publicado: (2017)

Understanding the andromeda strain – The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness
por: Mir, Nabiel, et al.
Publicado: (2021)

Inhibition of HCV by the serpin antithrombin III
por: Asmal, Mohammed, et al.
Publicado: (2012)

Proper diagnosis of antithrombin III deficiency
por: Özdemir, Zehra Narlı, et al.
Publicado: (2017)

Recommendations for VTE Prophylaxis in Medically Ill Patients
por: Skeik, Nedaa, et al.
Publicado: (2020)

Inhibition of neutrophil migration by the serpin antithrombin III
por: Dunzendorfer, S, et al.
Publicado: (2000)

Deficiency Of Antithrombin III (AT III) - Case Report and Review of the Literature
por: GĂMAN, AMELIA MARIA, et al.
Publicado: (2014)

UTILITY OF D-DIMER CUT-OFF POINT WITH VTE IN CRITICALLY ILL PATIENTS WITH COVID-19
por: ZHANG, RAINY, et al.
Publicado: (2021)

Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE
por: Xiong, Wei, et al.
Publicado: (2023)

Specific deactivation of monocyte and lymphocyte migration by antithrombin III
por: Reinisch, C, et al.
Publicado: (2001)

Strategy for Cardiovascular Surgery in Patients with Antithrombin III Deficiency
por: Nishimura, Yoshiyuki, et al.
Publicado: (2018)

Antithrombin III Protects Against Contrast-Induced Nephropathy
por: Lu, Zeyuan, et al.
Publicado: (2017)

Effect of Immobilized Antithrombin III on the Thromboresistance of Polycarbonate Urethane
por: Lukas, Karin, et al.
Publicado: (2017)

Current practice and the role of the CT in the management of penetrating liver injuries at a Level I trauma center
por: Schnüriger, Beat, et al.
Publicado: (2011)

Insight into Residues Critical for Antithrombin Function from an Expanded Database of Sequences That Includes Frog, Turtle and Ostrich Antithrombins
por: Backovic, Marija, et al.
Publicado: (2002)

Antithrombin III concentrate therapy may have an efficacy in sepsis
por: Saito, N, et al.
Publicado: (2013)

SerpinC1/Antithrombin III in kidney-related diseases
por: Lu, Zeyuan, et al.
Publicado: (2017)

The Association between the Level of Antithrombin III and Mortality in Children with Sepsis
por: Lestari, Indah Nur, et al.
Publicado: (2019)

Deciphering the role of trehalose in hindering antithrombin polymerization
por: Naseem, Asma, et al.
Publicado: (2019)

Single-dose application of antithrombin III as alternative anticoagulation during extracorporeal therapy in critically ill patients with advanced liver cirrhosis: a retrospective data analysis
por: Brunner, R, et al.
Publicado: (2011)

Inhibition of endotoxin-induced leukocyte/endothelial cell interaction by antithrombin III
por: Hoffmann, JN, et al.
Publicado: (1999)

Effect of antithrombin III on inflammatory immune response in patients with severe sepsis
por: Inthorn, D, et al.
Publicado: (1998)

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
por: van der Wall, Sake J., et al.
Publicado: (2018)

MASSIVE STROKE IN A CRITICALLY ILL COVID-19 POSITIVE PATIENT DESPITE DUAL ANTI-PLATELET THERAPY AND VTE PROPHYLAXIS
por: Nicholson, Michael, et al.
Publicado: (2020)

Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study
por: du Cheyron, Damien, et al.
Publicado: (2006)

VTE risk assessment in pregnancy
por: Ewins, Karl, et al.
Publicado: (2019)

Alteration of Antithrombin III and D-dimer Levels in Clinically Localized Prostate Cancer
por: Hong, Sung Kyu, et al.
Publicado: (2010)

Use of antithrombin III in cancer patients with sepsis complicated with disseminated intravascular coagulopathy
por: Polansky, M, et al.
Publicado: (1998)

Antithrombin III concentrate may contribute to sepsis in nonovert disseminated intravascular coagulation
por: Saito, Noriko, et al.
Publicado: (2013)

Antithrombin III expression predicts acute kidney injury in elderly patients with sepsis
por: Xie, Yun, et al.
Publicado: (2020)

Adequate Antithrombin III Level Predicts Survival in Severe COVID-19 Pneumonia
por: Joshi, Deepti, et al.
Publicado: (2021)

Potential of Antithrombin III as a Biomarker of Antidepressive Effect in Major Depressive Disorder
por: Song, Ruize, et al.
Publicado: (2021)

An Exceedingly Rare Case of Antithrombin III Deficiency and Catastrophic Antiphospholipid-Like Disease
por: Phan, Alexander T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_udiam9uthsgt7gkdksat6fdlfe